カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

世界の低侵襲女性尿失禁装置市場2022年：市場規模予測（～2028年）

■ 英語タイトル：Global Minimally Invasive Female Urinary Incontinence Devices Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR22MY8167）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR22MY8167
■ 発行日：2022年5月（※2025年版があります。お問い合わせください。）
■ 調査対象地域：グローバル
■ 産業分野：医療機器
■ ページ数：117
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥515,040見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥772,560見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,030,080見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界の低侵襲女性尿失禁装置市場2022年：市場規模予測（～2028年）]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

低侵襲女性尿失禁装置市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界の低侵襲女性尿失禁装置の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

低侵襲女性尿失禁装置市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・外部尿失禁装置、内部尿失禁装置

用途別セグメントは次のように区分されます。
・外来外科センター、婦人科クリニック、病院

世界の低侵襲女性尿失禁装置市場の主要な市場プレーヤーは以下のとおりです。
・Axonics Modulation Technologies, Inc、Bioness, Inc.、BlueWind Medical Ltd.、Boston Scientific Corporation、Caldera Medical, Inc.、Carbon Medical Technologies, Inc.、CL Medical、Cogentix Medical, Coloplast Corporation, Cousin Biotech、C. R. Bard, Inc. (Becton, Dickinson and Company)、Ethicon, Inc./Johnson & Johnson、FemPulse, LLC、InterStim, Medtronic, Inc.、Merz Aesthetics, Inc./Merz Pharma GmbH & Co. KGaA、NURO Sys、Nuvectra Corporation、StimGuard LLC.

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、低侵襲女性尿失禁装置製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な低侵襲女性尿失禁装置メーカーの企業概要、2019年～2022年までの低侵襲女性尿失禁装置の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な低侵襲女性尿失禁装置メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別低侵襲女性尿失禁装置の販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までの低侵襲女性尿失禁装置の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域での低侵襲女性尿失禁装置市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、および低侵襲女性尿失禁装置の産業チェーンを掲載しています。
・第13、14、15章では、低侵襲女性尿失禁装置の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
・メーカー情報（企業概要、製品概要、販売量、価格、売上）：Axonics Modulation Technologies, Inc、Bioness, Inc.、BlueWind Medical Ltd.、Boston Scientific Corporation、Caldera Medical, Inc.、Carbon Medical Technologies, Inc.、CL Medical、Cogentix Medical, Coloplast Corporation, Cousin Biotech、C. R. Bard, Inc. (Becton, Dickinson and Company)、Ethicon, Inc./Johnson & Johnson、FemPulse, LLC、InterStim, Medtronic, Inc.、Merz Aesthetics, Inc./Merz Pharma GmbH & Co. KGaA、NURO Sys、Nuvectra Corporation、StimGuard LLC.
・メーカー別市場シェア
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：外部尿失禁装置、内部尿失禁装置
・用途別分析2017年-2028年：外来外科センター、婦人科クリニック、病院
・低侵襲女性尿失禁装置の北米市場規模2017年-2028年：アメリカ、カナダ、メキシコ
・低侵襲女性尿失禁装置のヨーロッパ市場規模2017年-2028年：ドイツ、イギリス、フランス、ロシア、イタリア
・低侵襲女性尿失禁装置のアジア市場規模2017年-2028年：中国、日本、韓国、インド、東南アジア、オーストラリア
・低侵襲女性尿失禁装置の南米市場規模2017年-2028年：ブラジル、アルゼンチン
・低侵襲女性尿失禁装置の中東・アフリカ市場規模2017年-2028年：サウジアラビア、トルコ、エジプト、南アフリカ
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Minimally Invasive Female Urinary Incontinence Devices market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Minimally Invasive Female Urinary Incontinence Devices market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Ambulatory Surgical Centers accounting for % of the Minimally Invasive Female Urinary Incontinence Devices global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While External Urinary Incontinence Devices segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Minimally Invasive Female Urinary Incontinence Devices include Axonics Modulation Technologies, Inc, Bioness, Inc., BlueWind Medical Ltd., Boston Scientific Corporation, and Caldera Medical, Inc., etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Minimally Invasive Female Urinary Incontinence Devices market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
External Urinary Incontinence Devices
Internal Urinary Incontinence Devices
Market segment by Application can be divided into
Ambulatory Surgical Centers
Gynecology Clinics
Hospitals
The key market players for global Minimally Invasive Female Urinary Incontinence Devices market are listed below:
Axonics Modulation Technologies, Inc
Bioness, Inc.
BlueWind Medical Ltd.
Boston Scientific Corporation
Caldera Medical, Inc.
Carbon Medical Technologies, Inc.
CL Medical
Cogentix Medical, Coloplast Corporation, Cousin Biotech
C. R. Bard, Inc. (Becton, Dickinson and Company)
Ethicon, Inc./Johnson & Johnson
FemPulse, LLC
InterStim, Medtronic, Inc.
Merz Aesthetics, Inc./Merz Pharma GmbH & Co. KGaA
NURO Sys
Nuvectra Corporation
StimGuard LLC.
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Minimally Invasive Female Urinary Incontinence Devices product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Minimally Invasive Female Urinary Incontinence Devices, with price, sales, revenue and global market share of Minimally Invasive Female Urinary Incontinence Devices from 2019 to 2022.
Chapter 3, the Minimally Invasive Female Urinary Incontinence Devices competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Minimally Invasive Female Urinary Incontinence Devices breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Minimally Invasive Female Urinary Incontinence Devices market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Minimally Invasive Female Urinary Incontinence Devices.
Chapter 13, 14, and 15, to describe Minimally Invasive Female Urinary Incontinence Devices sales channel, distributors, customers, research findings and conclusion, appendix and data source.

*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Minimally Invasive Female Urinary Incontinence Devices Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Minimally Invasive Female Urinary Incontinence Devices Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 External Urinary Incontinence Devices
1.2.3 Internal Urinary Incontinence Devices
1.3 Market Analysis by Application
1.3.1 Overview: Global Minimally Invasive Female Urinary Incontinence Devices Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Ambulatory Surgical Centers
1.3.3 Gynecology Clinics
1.3.4 Hospitals
1.4 Global Minimally Invasive Female Urinary Incontinence Devices Market Size & Forecast
1.4.1 Global Minimally Invasive Female Urinary Incontinence Devices Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Minimally Invasive Female Urinary Incontinence Devices Sales in Volume (2017-2028)
1.4.3 Global Minimally Invasive Female Urinary Incontinence Devices Price (2017-2028)
1.5 Global Minimally Invasive Female Urinary Incontinence Devices Production Capacity Analysis
1.5.1 Global Minimally Invasive Female Urinary Incontinence Devices Total Production Capacity (2017-2028)
1.5.2 Global Minimally Invasive Female Urinary Incontinence Devices Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Minimally Invasive Female Urinary Incontinence Devices Market Drivers
1.6.2 Minimally Invasive Female Urinary Incontinence Devices Market Restraints
1.6.3 Minimally Invasive Female Urinary Incontinence Devices Trends Analysis
2 Manufacturers Profiles
2.1 Axonics Modulation Technologies, Inc
2.1.1 Axonics Modulation Technologies, Inc Details
2.1.2 Axonics Modulation Technologies, Inc Major Business
2.1.3 Axonics Modulation Technologies, Inc Minimally Invasive Female Urinary Incontinence Devices Product and Services
2.1.4 Axonics Modulation Technologies, Inc Minimally Invasive Female Urinary Incontinence Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Bioness, Inc.
2.2.1 Bioness, Inc. Details
2.2.2 Bioness, Inc. Major Business
2.2.3 Bioness, Inc. Minimally Invasive Female Urinary Incontinence Devices Product and Services
2.2.4 Bioness, Inc. Minimally Invasive Female Urinary Incontinence Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 BlueWind Medical Ltd.
2.3.1 BlueWind Medical Ltd. Details
2.3.2 BlueWind Medical Ltd. Major Business
2.3.3 BlueWind Medical Ltd. Minimally Invasive Female Urinary Incontinence Devices Product and Services
2.3.4 BlueWind Medical Ltd. Minimally Invasive Female Urinary Incontinence Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Boston Scientific Corporation
2.4.1 Boston Scientific Corporation Details
2.4.2 Boston Scientific Corporation Major Business
2.4.3 Boston Scientific Corporation Minimally Invasive Female Urinary Incontinence Devices Product and Services
2.4.4 Boston Scientific Corporation Minimally Invasive Female Urinary Incontinence Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Caldera Medical, Inc.
2.5.1 Caldera Medical, Inc. Details
2.5.2 Caldera Medical, Inc. Major Business
2.5.3 Caldera Medical, Inc. Minimally Invasive Female Urinary Incontinence Devices Product and Services
2.5.4 Caldera Medical, Inc. Minimally Invasive Female Urinary Incontinence Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Carbon Medical Technologies, Inc.
2.6.1 Carbon Medical Technologies, Inc. Details
2.6.2 Carbon Medical Technologies, Inc. Major Business
2.6.3 Carbon Medical Technologies, Inc. Minimally Invasive Female Urinary Incontinence Devices Product and Services
2.6.4 Carbon Medical Technologies, Inc. Minimally Invasive Female Urinary Incontinence Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 CL Medical
2.7.1 CL Medical Details
2.7.2 CL Medical Major Business
2.7.3 CL Medical Minimally Invasive Female Urinary Incontinence Devices Product and Services
2.7.4 CL Medical Minimally Invasive Female Urinary Incontinence Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Cogentix Medical, Coloplast Corporation, Cousin Biotech
2.8.1 Cogentix Medical, Coloplast Corporation, Cousin Biotech Details
2.8.2 Cogentix Medical, Coloplast Corporation, Cousin Biotech Major Business
2.8.3 Cogentix Medical, Coloplast Corporation, Cousin Biotech Minimally Invasive Female Urinary Incontinence Devices Product and Services
2.8.4 Cogentix Medical, Coloplast Corporation, Cousin Biotech Minimally Invasive Female Urinary Incontinence Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 C. R. Bard, Inc. (Becton, Dickinson and Company)
2.9.1 C. R. Bard, Inc. (Becton, Dickinson and Company) Details
2.9.2 C. R. Bard, Inc. (Becton, Dickinson and Company) Major Business
2.9.3 C. R. Bard, Inc. (Becton, Dickinson and Company) Minimally Invasive Female Urinary Incontinence Devices Product and Services
2.9.4 C. R. Bard, Inc. (Becton, Dickinson and Company) Minimally Invasive Female Urinary Incontinence Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Ethicon, Inc./Johnson & Johnson
2.10.1 Ethicon, Inc./Johnson & Johnson Details
2.10.2 Ethicon, Inc./Johnson & Johnson Major Business
2.10.3 Ethicon, Inc./Johnson & Johnson Minimally Invasive Female Urinary Incontinence Devices Product and Services
2.10.4 Ethicon, Inc./Johnson & Johnson Minimally Invasive Female Urinary Incontinence Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 FemPulse, LLC
2.11.1 FemPulse, LLC Details
2.11.2 FemPulse, LLC Major Business
2.11.3 FemPulse, LLC Minimally Invasive Female Urinary Incontinence Devices Product and Services
2.11.4 FemPulse, LLC Minimally Invasive Female Urinary Incontinence Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 InterStim, Medtronic, Inc.
2.12.1 InterStim, Medtronic, Inc. Details
2.12.2 InterStim, Medtronic, Inc. Major Business
2.12.3 InterStim, Medtronic, Inc. Minimally Invasive Female Urinary Incontinence Devices Product and Services
2.12.4 InterStim, Medtronic, Inc. Minimally Invasive Female Urinary Incontinence Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 Merz Aesthetics, Inc./Merz Pharma GmbH & Co. KGaA
2.13.1 Merz Aesthetics, Inc./Merz Pharma GmbH & Co. KGaA Details
2.13.2 Merz Aesthetics, Inc./Merz Pharma GmbH & Co. KGaA Major Business
2.13.3 Merz Aesthetics, Inc./Merz Pharma GmbH & Co. KGaA Minimally Invasive Female Urinary Incontinence Devices Product and Services
2.13.4 Merz Aesthetics, Inc./Merz Pharma GmbH & Co. KGaA Minimally Invasive Female Urinary Incontinence Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14 NURO Sys
2.14.1 NURO Sys Details
2.14.2 NURO Sys Major Business
2.14.3 NURO Sys Minimally Invasive Female Urinary Incontinence Devices Product and Services
2.14.4 NURO Sys Minimally Invasive Female Urinary Incontinence Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15 Nuvectra Corporation
2.15.1 Nuvectra Corporation Details
2.15.2 Nuvectra Corporation Major Business
2.15.3 Nuvectra Corporation Minimally Invasive Female Urinary Incontinence Devices Product and Services
2.15.4 Nuvectra Corporation Minimally Invasive Female Urinary Incontinence Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.16 StimGuard LLC.
2.16.1 StimGuard LLC. Details
2.16.2 StimGuard LLC. Major Business
2.16.3 StimGuard LLC. Minimally Invasive Female Urinary Incontinence Devices Product and Services
2.16.4 StimGuard LLC. Minimally Invasive Female Urinary Incontinence Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Minimally Invasive Female Urinary Incontinence Devices Breakdown Data by Manufacturer
3.1 Global Minimally Invasive Female Urinary Incontinence Devices Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Minimally Invasive Female Urinary Incontinence Devices Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Minimally Invasive Female Urinary Incontinence Devices
3.4 Market Concentration Rate
3.4.1 Top 3 Minimally Invasive Female Urinary Incontinence Devices Manufacturer Market Share in 2021
3.4.2 Top 6 Minimally Invasive Female Urinary Incontinence Devices Manufacturer Market Share in 2021
3.5 Global Minimally Invasive Female Urinary Incontinence Devices Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Minimally Invasive Female Urinary Incontinence Devices Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Minimally Invasive Female Urinary Incontinence Devices Market Size by Region
4.1.1 Global Minimally Invasive Female Urinary Incontinence Devices Sales in Volume by Region (2017-2028)
4.1.2 Global Minimally Invasive Female Urinary Incontinence Devices Revenue by Region (2017-2028)
4.2 North America Minimally Invasive Female Urinary Incontinence Devices Revenue (2017-2028)
4.3 Europe Minimally Invasive Female Urinary Incontinence Devices Revenue (2017-2028)
4.4 Asia-Pacific Minimally Invasive Female Urinary Incontinence Devices Revenue (2017-2028)
4.5 South America Minimally Invasive Female Urinary Incontinence Devices Revenue (2017-2028)
4.6 Middle East and Africa Minimally Invasive Female Urinary Incontinence Devices Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Minimally Invasive Female Urinary Incontinence Devices Sales in Volume by Type (2017-2028)
5.2 Global Minimally Invasive Female Urinary Incontinence Devices Revenue by Type (2017-2028)
5.3 Global Minimally Invasive Female Urinary Incontinence Devices Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Minimally Invasive Female Urinary Incontinence Devices Sales in Volume by Application (2017-2028)
6.2 Global Minimally Invasive Female Urinary Incontinence Devices Revenue by Application (2017-2028)
6.3 Global Minimally Invasive Female Urinary Incontinence Devices Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Minimally Invasive Female Urinary Incontinence Devices Sales by Type (2017-2028)
7.2 North America Minimally Invasive Female Urinary Incontinence Devices Sales by Application (2017-2028)
7.3 North America Minimally Invasive Female Urinary Incontinence Devices Market Size by Country
7.3.1 North America Minimally Invasive Female Urinary Incontinence Devices Sales in Volume by Country (2017-2028)
7.3.2 North America Minimally Invasive Female Urinary Incontinence Devices Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Minimally Invasive Female Urinary Incontinence Devices Sales by Type (2017-2028)
8.2 Europe Minimally Invasive Female Urinary Incontinence Devices Sales by Application (2017-2028)
8.3 Europe Minimally Invasive Female Urinary Incontinence Devices Market Size by Country
8.3.1 Europe Minimally Invasive Female Urinary Incontinence Devices Sales in Volume by Country (2017-2028)
8.3.2 Europe Minimally Invasive Female Urinary Incontinence Devices Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Minimally Invasive Female Urinary Incontinence Devices Sales by Type (2017-2028)
9.2 Asia-Pacific Minimally Invasive Female Urinary Incontinence Devices Sales by Application (2017-2028)
9.3 Asia-Pacific Minimally Invasive Female Urinary Incontinence Devices Market Size by Region
9.3.1 Asia-Pacific Minimally Invasive Female Urinary Incontinence Devices Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Minimally Invasive Female Urinary Incontinence Devices Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Minimally Invasive Female Urinary Incontinence Devices Sales by Type (2017-2028)
10.2 South America Minimally Invasive Female Urinary Incontinence Devices Sales by Application (2017-2028)
10.3 South America Minimally Invasive Female Urinary Incontinence Devices Market Size by Country
10.3.1 South America Minimally Invasive Female Urinary Incontinence Devices Sales in Volume by Country (2017-2028)
10.3.2 South America Minimally Invasive Female Urinary Incontinence Devices Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Minimally Invasive Female Urinary Incontinence Devices Sales by Type (2017-2028)
11.2 Middle East & Africa Minimally Invasive Female Urinary Incontinence Devices Sales by Application (2017-2028)
11.3 Middle East & Africa Minimally Invasive Female Urinary Incontinence Devices Market Size by Country
11.3.1 Middle East & Africa Minimally Invasive Female Urinary Incontinence Devices Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Minimally Invasive Female Urinary Incontinence Devices Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Minimally Invasive Female Urinary Incontinence Devices and Key Manufacturers
12.2 Manufacturing Costs Percentage of Minimally Invasive Female Urinary Incontinence Devices
12.3 Minimally Invasive Female Urinary Incontinence Devices Production Process
12.4 Minimally Invasive Female Urinary Incontinence Devices Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Minimally Invasive Female Urinary Incontinence Devices Typical Distributors
13.3 Minimally Invasive Female Urinary Incontinence Devices Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer



*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 世界の低侵襲減量（Bariatric）装置市場2022年：市場規模予測（～2028年）
  • 世界の低侵襲変形矯正システム市場2022年：市場規模予測（～2028年）
  • 世界の低侵襲手術用開創器市場2022年：市場規模予測（～2028年）
  • 世界の低侵襲減量手術装置市場2022年：市場規模予測（～2028年）
  • 世界のマイクロ侵襲性緑内障手術（MIGS）装置市場2022年：市場規模予測（～2028年）
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR22MY8167 )"世界の低侵襲女性尿失禁装置市場2022年：市場規模予測（～2028年）" (英文：Global Minimally Invasive Female Urinary Incontinence Devices Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。